DrugSpaceX

DrugSpaceX provides a virtual compound library generated by transforming approved drug molecules to produce over 100 million novel, structurally diverse, three-dimensional, and synthesizable chemical structures for virtual screening and drug discovery.


Key Features:

  • Enumeration from approved drugs: Generates over 100 million novel chemical structures by applying transformations to approved drug molecules.
  • Structural novelty and diversity: Produces structurally novel and diverse compounds with extensive three-dimensional chemical space coverage.
  • Synthesizability focus: Emphasizes generation of synthesizable compounds suitable for downstream medicinal chemistry.
  • Downloadable subsets: Provides selectable subsets including a 10% diversity subset, an extended drug-like subset, a standard drug-like subset, a lead-like subset, and a fragment-like subset.
  • Transformation annotation: Includes detailed transformation instructions and records the position of each transformation within molecules.
  • Virtual screening-ready: Supplies compound collections intended for use in virtual screening workflows.
  • Case study validation: Demonstrated identification of initial hit compounds for discoidin domain receptor 1 (DDR1) kinase.

Scientific Applications:

  • Virtual screening: Use the enumerated library and subsets for in silico screening campaigns against biological targets.
  • Hit identification and lead discovery: Support initial hit finding and progression toward lead compounds, as shown for DDR1 kinase.
  • Ligand identification and optimization: Aid medicinal chemistry in ligand design, strategic planning, and protection-group considerations via transformation annotations.
  • Subset-guided selection: Enable selection of compounds based on desired chemical properties using predefined subsets (diversity, drug-like, lead-like, fragment-like).

Methodology:

Enumerates novel compounds by applying expert-defined transformations to approved drug molecules, generates multiple downloadable subsets (10% diversity, extended drug-like, standard drug-like, lead-like, fragment-like), and records the position of each transformation within molecules.

Topics

Details

Tool Type:
web application
Added:
1/18/2021
Last Updated:
11/24/2024

Operations

Publications

Yang T, Li Z, Chen Y, Feng D, Wang G, Fu Z, Ding X, Tan X, Zhao J, Luo X, Chen K, Jiang H, Zheng M. DrugSpaceX: a large screenable and synthetically tractable database extending drug space. Nucleic Acids Research. 2020;49(D1):D1170-D1178. doi:10.1093/nar/gkaa920. PMID:33104791. PMCID:PMC7778939.

PMID: 33104791
PMCID: PMC7778939
Funding: - National Natural Science Foundation of China: 81773634 - National Science & Technology: 2018ZX09711002 - Chinese Academy of Sciences: XDA12050201

Downloads